Profilo
Paul Schaffer currently works at Telix Pharmaceuticals Ltd., as Chief Technology Officer from 2025.
Dr. Schaffer also formerly worked at Centre For Probe Development & Commercialization, as Director from 2018 to 2021 and ARTMS, Inc., as Chief Technology Officer from 2018 to 2025.
Posizioni attive di Paul Schaffer
| Società | Posizione | Inizio |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Direttore Tecnico/Scientifico/R&S | 07/04/2025 |
Precedenti posizioni note di Paul Schaffer
| Società | Posizione | Fine |
|---|---|---|
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Amministratore Delegato | 28/03/2018 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Direttore/Membro del Consiglio | 17/06/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
















